Treatment of severe liver failure with a bioartificial liver

Annals of the New York Academy of Sciences

Volumn 831, Issue , 1997, Pages 350-360

  Chen, Steve C ^a   Mullon, Claudy ^b   Kahaku, Elaine ^a   Watanabe, Fred ^a   Hewitt, Winston ^a   Eguchi, Susumu ^a   Middleton, Yvette ^a   Arkadopoulos, Nikolaos ^a   Rozga, Jacek ^a   Solomon, Barry ^b   Demetriou, Achilles A ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Grace Biomedical   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTIFICIAL LIVER; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; GRAFT SURVIVAL; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; SCHOOL CHILD;

SUIDAE;

EID: 0031593183     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb52210.x     Document Type: Conference Paper

References (36)

1. SHEIL, A. G. R., G. W. MCCAUGHAN, H. ISAI, et al. 1991. Acute and subacute fulminant hepatic failure: The role of liver transplantation. Med. J. Australia 154: 724-728.
2. O'GRADY, J. G., A. E. S. GIMSON, C. J. O'BRIEN, et al. 1988. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 94: 1186-1192.
3. NEUZIL, D. F., J. ROZGA, A. D. MOSCIONI, et al. 1993. Use of a novel bioartificial liver in a patient with acute liver insufficiency. Surgery 113: 340-343.
4. ROZGA, J., M. D. HOLZMAN, M.-S. RO, et al. 1993. Hybrid bioartificial liver support treatment of animals with severe ischemic liver failure. Ann. Surg. 217: 502-511.
5. ROZGA J., F. WILLIAMS, M.-S. RO, et al. 1993. Development of a bioartificial liver: Properties and function of a hollow-fiber module inoculated with liver cells. Hepatology 17: 258-265.
6. DEMETRIOU, A. A., J. ROZGA, L. PODESTA, et al. 1995. Early clinical experience with a bioartificial liver. Scand. J. Gastroenterol. 30(Suppl 208): 111-117.
7. TREY, C. & C. DAVIDSON. 1970. The management of fulminant hepatic failure. Prog. Liver Dis. 3: 282-298.
8. O'GRADY, J., S. W. SCHALM & R. WILLIAMS. 1993. Acute liver failure: Redefining the syndromes. Lancet 342: 273-275.
9. BERNUAU, J. & J. P. BENHAMOU. 1993. Classifying acute liver failure. Lancet 342: 252.
10. PAPPAS, S. C. 1988. Fulminant hepatic failure and need for artificial liver support. Mayo Clin. Proc. 63: 198-200.
11. STANCZAK, D. E., J. G. WHITE III, W. D. GOUVIEW, et al. 1984. Assessment of level of consciousness following severe neurological insult. J. Neurosurg. 60: 955-960.
12. DEMETRIOU, A. A. Ed. 1994. Support of the acutely failing liver. Medical Intelligent Unit, R. G. Landes Co. Austin, TX.
13. ROZGA, J., E. LEPAGE, A. D. MOSCIONI, et al. 1994. Clinical use of a bioartificial liver to treat fulminant hepatic failure. Ann. Surg. 219: 538-546.
14. KONG, L. B., S. CHEN, A. A. DEMETRIOU & J. ROZGA. 1995. Matrix-induced liver cell aggregates (MILCA) for bioartificial liver use. Int. J. Artif. Organs 18: 43-49.
15. MORSIANI, E., J. ROZGA, H. C. SCOTT, et al. 1995. Automated liver cell processing facilitates large scale isolation and purification of porcine hepatocytes. ASAIO J. 41: 155-161.
16. RECORD, C. O., B. BUXTON, R. A. CHASE, et al. 1976. Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur. J. Clin. Invest. 6: 387-394.
17. JAMES, J. H., B. JEPPSON, U. ZIPARO & J. E. FISCHER. 1979. Hyperammonemia, plasma amino acid imbalance and blood brain amino acid transport: A unified theory of portal hepatic encephalopathy. Lancet ii: 772-775.
18. LEE, W. 1994. Acute liver failure. N. Engl. J. Med. 329(25): 1862-1872.
19. BURNELL, J. M., C. RUNGE, F. C. SAUNDERS, E. D. THOMAS & W. VOLWILER. 1973. Acute hepatic failure treated by cross circulation. Arch. Intern. Med. 132: 493-498.
20. BIHARI, D., R. D. HUGHES, A. E. S. GIMSON, et al. 1983. Effects of serial resin hemoperfusion in fulminant hepatic failure. Int. J. Artif. Organs 6: 299-302.
21. PARBHOO, S. P., I. M. JAMES, A. AJDUKIEWICZ, et al. 1971. Extracorporeal pig liver perfusion in treatment of hepatic coma due to fulminant hepatitis. Lancet ii: 659-665.
22. ABOUNA, G. M., J. S. COOK, L. M. A. FISHER, et al. 1972. Treatment of acute hepatic coma by ex vivo baboon and human liver perfusion. Surgery 71: 537-546.
23. GIMSON, A. E. S., P. J. MELLON, S. BRAUDE, et al. 1982. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet ii: 68-83.
24. SMITH, J. W., S. MATSUBARA, T. HORIUCHI, et al. 1982. Sorption-filtration therapy for chronic liver disease in vivo testing and clinical correlation. Trans. Am. Soc. Artif. Intern. Organs 28: 215-219.
25. O'GRADY, J. G., A. E. S. GIMSON, C. J. O'BRIEN, et al. 1988. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 94: 1186-1192.
26. SILK, D. B. A., P. N. TREWBY, R. A. CHASE, et al. 1977. Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis. Lancet ii: 1-3.
27. DENIS, J., P. OPOLON, V. NUSINOVICI, et al. 1978. Treatment of encephalopathy during fulminant hepatic failure by hemodialysis with high permeability membrane. Gut 19: 787-793.
28. REDEKER, A. G. & H. S. YAMAHIRO. 1973. Controlled trial of exchange transfusion therapy in fulminant hepatitis. Lancet ii: 3-6.
29. COOPER, G. N., K. E. KARLSON, G. H. A. CLOWES, et al. 1977. Total body washout and exchange. A valuable tool in acute hepatic coma and Reye's syndrome. Am. J. Surg. 133: 522-530.
30. DENTI, E. & M. P. LUBOZ. 1974. Preparation and properties of gel-entrapped liver cell microsomes. In Artificial Liver Support. R. Williams and I. M. Murray Lyon, Eds.: 148-152. Pitman Medical.
31. USAMI, M., H. OHYANAGI, S. NISHIMATSU, et al. 1989. Therapeutic plasmapheresis for liver failure after hepatectomy. Trans. Am. Soc. Artif. Intern. Organs. 35: 564-567.
32. OLUMIDE, F., A. ELIASHIV, N. KRALIOS, et al. 1977. Hepatic support with hepatocyte suspensions in a permeable membrane dialyzer. Surgery 82: 599-606.
33. YANAGI, K., K. OOKAWA, M. SHUICHI, et al. 1989. Performance of a new hybrid artificial liver support system using hepatocytes entrapped within a hydrogel. Trans. Am. Soc. Artif Intern. Organs 35: 570-572.
34. MATSUMURA, K. N., G. R. GUEVARA, H. HUSTION, et al. 1987. Hybrid bioartificial liver in hepatic failure: Preliminary clinical report. Surgery 101: 99-103.
35. SAITO, S., K. SAKAGAMI & K. ORITA. 1987. A new hybrid artificial liver using a combination of hepatocytes and biomatrix. Trans. Am. Soc. Artif. Intern. Organs 33: 459-462.
36. FOX, I. J., A. N. LANGNAS, C. F. OZAKI, et al. 1993. Successful application of extracorporeal liver perfusion for the treatment of fulminant hepatic failure: A technology whose time has come. Am. J. Gastroenterol. 88: 1876-1881.